Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Sanofi offers a year of salary to employees facing cancer, critical illnesses

By Brian Buntz | February 5, 2024

Sanofi logoFrench pharma giant Sanofi launched a new global program aimed at providing financial, social and emotional assistance to employees diagnosed with cancer or other critical illnesses.

Dubbed “Cancer & Work: Acting Together,” the program guarantees continued salary and benefits for up to one year for affected staff regardless of role or location. It also incorporates flexible work options to help employees balance treatment with their responsibilities.

“The last thing you want to be thinking about when diagnosed with cancer is work,” said Natalie Bickford, Sanofi’s Chief People Officer, in a statement. “I am delighted that Sanofi has gone further, guaranteeing job security and salary continuation for at least a year after diagnosis.”

Program offers more than financial support

In addition to the financial safeguards, the program provides access to trained volunteer employees who have dealt with cancer themselves and can offer advice and support. Psychological counseling services are also available globally to participating staff.

Sanofi intends to offer coverage for miscellaneous non-medical expenses in 2024 to participants in the program. The initiative will also offer unpaid caregiver leave to permanent employees caring for relatives with critical illnesses.

The support program was inspired by a grassroots employee initiative launched in France in 2017. The volunteer-based employee program offered support to affected employees and an opportunity to connect with colleagues with similar experiences. Since then, the program  has grown to include 27 local teams with more than 150 volunteer members across Sanofi sites in France.

Merck and AbbVie among other Big Pharmas with creative employee health programs

Other Big Pharmas have launched programs designed to support colleagues with significant health concerns. During the early days of the pandemic, for instance, Merck & Co. launched a comprehensive wellbeing program focused on the COVID-19 and physical, mental and emotional health. Described in its 2020/2021 Annual Wellbeing Report, the program focuses on offered expanded health programs, compensation for COVID-19 related expenses, expanded child and elder care support, and new resources for remote working and mental health support.

In another example, AbbVie has developed a program to support employees suffering from migraines, recognizing the condition as the second-most disabling worldwide. The company is implementing migraine-friendly workspaces that include features like natural lighting, quiet rooms, and filtered air to reduce potential migraine triggers. This initiative is part of the company’s broader commitment to the health and well-being of its employees.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE